Mitchell, A. P., Harrison, M. R., George, D. J., Abernethy, A. P., Walker, M. S., & Hirsch, B. R. (2014). Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials. In Journal of Clinical Oncology (Vol. 32, pp. 6510–6510). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.6510

Mitchell, Aaron Philip, Michael Roger Harrison, Daniel J. George, Amy Pickar Abernethy, Mark S. Walker, and Bradford Richard Hirsch. “Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials.” In Journal of Clinical Oncology, 32:6510–6510. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.6510.

Mitchell AP, Harrison MR, George DJ, Abernethy AP, Walker MS, Hirsch BR. Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 6510–6510.

Mitchell, Aaron Philip, et al. “Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 6510–6510. Crossref, doi:10.1200/jco.2014.32.15_suppl.6510.

Mitchell AP, Harrison MR, George DJ, Abernethy AP, Walker MS, Hirsch BR. Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 6510–6510.